Navid Shomali

9PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 17, 2023
An updated overview of the application of CAR-T cell therapy in neurological diseases.

Hesam Shahabifard, Mahdi Zarei, Keihan Kookli

|Nov 09, 2022
MicroRNA-155 acts as a potential prognostic and diagnostic factor in patients with ankylosing spondylitis by modulating SOCS3.

Mohammadsaleh Jahangir, Mohammad Saeed Kahrizi, Mohammad Natami

|Aug 08, 2022
The role of immune regulatory molecules in rheumatoid arthritis: Implication for etiopathogenesis and prospective for treatment.

Maryam Hemmatzadeh, Elham Ahangar Parvin, Hamed Mohammadi

|Jun 28, 2022
Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advances.

Marzieh Nikoo, Mohammad Rudiansyah, Dmitry Olegovich Bokov

|Sep 19, 2021
PD-1/PD-L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity.

Ramin Hosseinzadeh, Fahimeh Feizisani, Navid Shomali

|Jun 12, 2021
The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.

Roza Motavalli, Walid Kamal Abdelbasset, Heshu Sulaiman Rahman

Pageof 2

Frequent Collaborators

4 joint publications

Hamed Mohammadi

2 joint publications

Maryam Hemmatzadeh

2 joint publications

Farhad Jadidi-Niaragh

1 joint publications

Mina Deljavanghodrati